Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on October 2, 2025
October 2, 2025
Angels for Change Announces 2025 Change Maker of the Year: Vimala Raghavendran
Indeterminate
EIN Presswire
October 2, 2025
What the New ACA Bill Means and How Health Sharing Offers a Practical Alternative in 2025
Indeterminate
EIN Presswire
October 2, 2025
HELP Conference 2025 in Jupiter, FL: Join Leaders Addressing the Root Causes of Chronic Disease
Indeterminate
EIN Presswire
October 2, 2025
InfuCare Rx® Opens New Bradenton Infusion Suite to Deliver Patient-Centered Care
Indeterminate
EIN Presswire
October 2, 2025
Mindcore Technologies Highlights Growing Demand for Secure Workspace Solutions Across Regulated Industries
Indeterminate
EIN Presswire
October 2, 2025
Tampa Plastic Surgeon on Choosing a Provider
Indeterminate
EIN Presswire
October 2, 2025
DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
Indeterminate
EIN Presswire
October 2, 2025
VA and DoD contract brings FDA-registered safe patient handling equipment to clinics nationwide
Indeterminate
EIN Presswire
October 2, 2025
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
Indeterminate
GlobeNewswire
October 2, 2025
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 2, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
Indeterminate
GlobeNewswire
October 2, 2025
Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
Indeterminate
GlobeNewswire
October 2, 2025
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
Indeterminate
GlobeNewswire
October 2, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire